Evidence map›Paper›PMID 18985146›Full record

Trial reportPloS one2008

Elevated stress-hemoconcentration in major depression is normalized by antidepressant treatment: secondary analysis from a randomized, double-blind clinical trial and relevance to cardiovascular disease risk.

Ma-Li Wong, Chuanhui Dong, Karin Esposito, Sarika Thakur, Weiqing Liu, Robert M Elashoff, Julio Licinio

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Does Blood Flow Change according to Mood? Blood Rheology in Bipolar Disorder.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2018
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis.Medical science monitor : international medical journal of experimental and clinical research · 2011
    Review
  15. Pathophysiological basis of cardiovascular disease and depression: a chicken-and-egg dilemma.Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) · 2010
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ma-Li WongDepartment of Psychiatry and Behavioral Sciences, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida, USA. mali@miami.edu
Chuanhui Dong
Karin Esposito
Sarika Thakur
Weiqing Liu
Robert M Elashoff
Julio Licinio
University of Miami · USUniversity of California, Los Angeles · US

Funding

ZDV &3TC NEVIRAPINE COMBINATION THERAPY IN HIV 1 INFECTED INFANTS &M01RR000865 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WASHINGTON, ARNOLD E. · 1985 to 2011
$43.4M
UCLA PHARMACOGENETICS &PHARMACOGENOMICS RESEARCH GROUPU01GM061394 · NIGMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LICINIO, JULIO · 2000 to 2005
$4.7M
Depression/Metabolic Syndrome in Mexican-American Women.R01DK063240 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI WONG, MA-LI · 2002 to 2006
$1.9M
Pharmacogenetics of Antidepressant DrugsK24RR017365 · NCRR · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI WONG, MA-LI · 2003 to 2007
$727k
Clinical Neuroendocrinology of LeptinK24RR016996 · NCRR · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LICINIO, JULIO · 2002 to 2006
$662k
Developing Educational Approaches for Mexican-AmericansR03HG002500 · NHGRI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LICINIO, JULIO · 2002 to 2005
$392k
CNS transcription modulation in peripheral inflammationR21MH062777 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WONG, MA-LI · 2001 to 2002
$306k
NCRR NIH HHS K24 RR016996NCRR NIH HHS K24 RR017365NCRR NIH HHS M01 RR000865NCRR NIH HHS RR000865NCRR NIH HHS RR017365NCRR NIH HHS RR16996NHGRI NIH HHS HG002500NHGRI NIH HHS R03 HG002500NIDDK NIH HHS DK063240NIDDK NIH HHS R01 DK063240NIGMS NIH HHS GM61394NIGMS NIH HHS U01 GM061394NIMH NIH HHS MH062777
6 · The paper itself

Abstract

backgroundMajor depressive disorder (MDD) is an independent risk factor for cardiovascular disease (CVD); the presence of MDD symptoms in patients with CVD is associated with a higher incidence of cardiac complications following acute myocardial infarction (MI). Stress-hemoconcentration, a result of psychological stress that might be a risk factor for the pathogenesis of CVD, has been studied in stress-challenge paradigms but has not been systematically studied in MDD.

methodsSecondary analysis of stress hemoconcentration was performed on data from controls and subjects with mild to moderate MDD participating in an ongoing pharmacogenetic study of antidepressant treatment response to desipramine or fluoxetine. Hematologic and hemorheologic measures of stress-hemoconcentration included blood cell counts, hematocrit, hemoglobin, total serum protein, and albumin, and whole blood viscosity.

findingsSubjects with mild to moderate MDD had significantly increased hemorheologic measures of stress-hemoconcentration and blood viscosity when compared to controls; these measures were correlated with depression severity. Measures of stress-hemoconcentration improved significantly after 8 weeks of antidepressant treatment. Improvements in white blood cell count, red blood cell measures and plasma volume were correlated with decreased severity of depression.

conclusionsOur secondary data analyses support that stress-hemoconcentration, possibly caused by decrements in plasma volume during psychological stress, is present in Mexican-American subjects with mild to moderate MDD at non-challenged baseline conditions. We also found that after antidepressant treatment hemorheologic measures of stress-hemoconcentration are improved and are correlated with improvement of depressive symptoms. These findings suggest that antidepressant treatment may have a positive impact in CVD by ameliorating increased blood viscosity. Physicians should be aware of the potential impact of measures of hemoconcentration and consider the implications for cardiovascular risk in depressed patients.

Indexed as

AdultAgedAntidepressive AgentsBlood ProteinsCardiovascular DiseasesDouble-Blind MethodFemaleHematocritHemoglobinsHumansMajor Depressive DisorderMaleMiddle AgedRisk FactorsStress, PsychologicalAntidepressive AgentsBlood ProteinsHemoglobins

Identifiers

PMID18985146
PMCPMC2391294
OpenAlexW2055383398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.